Synapsoft logo
AI Insights from Disclosures
Searching...
WHANIN PHARM CO.,LTD 016580
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
WHANIN PHARM CO.,LTD's main business is manufacturing pharmaceuticals and selling them to hospitals and other institutions, with central nervous system drugs accounting for more than 80% of total company revenue. Based on 2023 IMS DATA, the company ranks first in the domestic psychiatric drug market share and has continued steady growth through strong sales capability.
Representative Director 이광식, 이원범(각자 대표이사)
Founded December 16, 1982
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0339542
Business number 215-81-36171
Phone Number 02-405-3000
Fax Number 02-404-2518
Company Address 11 Beobwon-ro 6-gil, Songpa-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant